Avenue therapeutics to present at aegis capital virtual conference

Miami, april 27, 2023 (globe newswire) -- avenue therapeutics, inc. (nasdaq: atxi) (“avenue” or the “company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced that alexandra maclean, m.d., chief executive officer, will present a corporate update at the aegis capital virtual conference taking place on thursday, may 4, 2023, at 4:00 p.m. edt.
ATXI Ratings Summary
ATXI Quant Ranking